Pharmaceuticals Companies’ Medication Assistance Programs: Potentially Useful but Too Burdensome to Use?
- 1 February 2009
- journal article
- Published by Southern Medical Association in Southern Medical Journal
- Vol. 102 (2) , 139-144
Abstract
Objectives:This study examined how physicians perceive pharmaceutical companies’ medication assistance programs (MAPs).Methods:The study was conducted using a survey of 373 primary care physicians from four southern states; they were surveyed within the formative evaluation phase of a larger study (MI-Plus). Respondents were queried about use and usefulness of MAPs for patients who cannot...Keywords
This publication has 17 references indexed in Scilit:
- Cost-Related Medication Nonadherence and Spending on Basic Needs Following Implementation of Medicare Part DJAMA, 2008
- Pharmaceutical Patient Assistance Programs: Don't Look a Gift Horse in the Mouth or There's No Such Thing as a Free LunchJournal of Managed Care Pharmacy, 2007
- Patient-Reported Underuse of Prescription Medications: A Comparison of Nine SurveysMedical Care Research and Review, 2006
- A cancer drug shows promise, at a price that many can't pay.2006
- Outpatient medication assistance program in a rural settingAmerican Journal of Health-System Pharmacy, 2004
- Impact of an Annual Dollar Limit or "Cap" on Prescription Drug Benefits for Medicare PatientsJAMA, 2003
- Establishing an On-site Pharmacy in a Community Health Center to Help Indigent Patients Access Medications and to Improve CareJournal of the American Pharmaceutical Association, 2002
- Pharmaceutical Manufacturer Assistance ProgramsArchives of internal medicine (1960), 2002
- Impact of the Cost of Prescription Drugs on Clinical Outcomes in Indigent Patients with Heart DiseasePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2001
- Accessing Patient Assistance Programs to Meet Clients' Medication NeedsJournal of the American Academy of Nurse Practitioners, 2000